Neisseria gonorrhoeae: Difference between revisions
No edit summary |
No edit summary |
||
| Line 20: | Line 20: | ||
==Disposition== | ==Disposition== | ||
==Antibiotic Sensitivities<ref>Sanford Guide to Antimicrobial Therapy 2010</ref>== | |||
{| class="wikitable" | |||
| align="center" style="background:#f0f0f0;"|'''Antibiotics''' | |||
| align="center" style="background:#f0f0f0;"|'''''' | |||
| align="center" style="background:#f0f0f0;"|'''N. gonorrhoeae''' | |||
|- | |||
| Penicillins||Penicillin G||0 | |||
|- | |||
| ||Penicillin V||0 | |||
|- | |||
| Anti-Staphylocccal Penicillins||Methicillin||0 | |||
|- | |||
| ||Nafcillin/Oxacillin||0 | |||
|- | |||
| ||Cloxacillin/Diclox.||0 | |||
|- | |||
| Amino-Penicillins||AMP/Amox||0 | |||
|- | |||
| ||Amox/Clav||+ | |||
|- | |||
| ||AMP-Sulb||+ | |||
|- | |||
| Anti-Pseudomonal Penicillins||Ticarcillin||+ | |||
|- | |||
| ||Ticar-Clav||+ | |||
|- | |||
| ||Pip-Taxo||+ | |||
|- | |||
| [[Carbapenems]]||Piperacillin||+ | |||
|- | |||
| ||Doripenem||+ | |||
|- | |||
| ||Ertapenem||+ | |||
|- | |||
| ||Imipenem||+ | |||
|- | |||
| ||Meropenem||+ | |||
|- | |||
| ||[[Aztreonam]]||+ | |||
|- | |||
| [[Fluroquinolones]]||[[Ciprofloxacin]]||+* | |||
|- | |||
| ||Ofloxacin||+* | |||
|- | |||
| ||Pefloxacin||+* | |||
|- | |||
| ||[[Levofloxacin]]||+* | |||
|- | |||
| ||Moxifloxacin||+* | |||
|- | |||
| ||Gemifloxacin|| | |||
|- | |||
| ||Gatifloxacin||+* | |||
|- | |||
| 1st G [[Cephalosporin]]||Cefazolin||+ | |||
|- | |||
| 2nd G. [[Cephalosporin]]||[[Cefotetan]]||+/- | |||
|- | |||
| ||Cefoxitin||+/- | |||
|- | |||
| ||Cefuroxime||+/- | |||
|- | |||
| 3rd/4th G. [[Cephalosporin]]||[[CefoTAXime]]||+/- | |||
|- | |||
| ||Cefizoxime||+/- | |||
|- | |||
| ||[[CefTRIAXone]]||+ | |||
|- | |||
| ||Ceftobiprole||+ | |||
|- | |||
| ||Ceftaroline||+ | |||
|- | |||
| ||[[CefTAZidime]]||+/- | |||
|- | |||
| ||[[Cefepime]]||+ | |||
|- | |||
| Oral 1st G. [[Cephalosporin]]||Cefadroxil||0 | |||
|- | |||
| ||[[Cephalexin]]||0 | |||
|- | |||
| Oral 2nd G. [[Cephalosporin]]||Cefaclor/Loracarbef||+/- | |||
|- | |||
| ||Cefproxil||+/- | |||
|- | |||
| ||Cefuroxime axetil||+/- | |||
|- | |||
| Oral 3rd G. [[Cephalosporin]]||Cefixime||+ | |||
|- | |||
| ||Ceftibuten||+/- | |||
|- | |||
| ||Cefpodox/Cefdinir/Cefditoren||+ | |||
|- | |||
| [[Aminoglycosides]]||[[Gentamicin]]||0 | |||
|- | |||
| ||Tobramycin||0 | |||
|- | |||
| ||[[Amikacin]]||0 | |||
|- | |||
| ||Chloramphenicol||+ | |||
|- | |||
| ||[[Clindamycin]]||0 | |||
|- | |||
| [[Macrolides]]||Erythromycin||+/- | |||
|- | |||
| ||[[Azithromycin]]||+/- | |||
|- | |||
| ||Clarithromycin||+/- | |||
|- | |||
| Ketolide||Telithromycin||+ | |||
|- | |||
| Tetracyclines||[[Doxycycline]]||+/- | |||
|- | |||
| ||Minocycline||+/- | |||
|- | |||
| Glycylcycline||Tigecycline||+ | |||
|- | |||
| Glyco/Lipoclycopeptides||[[Vancomycin]]||0 | |||
|- | |||
| ||Teicoplanin||0 | |||
|- | |||
| ||Telavancin||0 | |||
|- | |||
| ||Fusidic Acid||+ | |||
|- | |||
| ||Trimethoprim||0 | |||
|- | |||
| ||[[TMP-SMX]]||+/- | |||
|- | |||
| Urinary Agents||[[Nitrofurantoin]]||+ | |||
|- | |||
| ||Fosfomycin||+ | |||
|- | |||
| Other||[[Rifampin]]||+ | |||
|- | |||
| ||[[Metronidazole]]||0 | |||
|- | |||
| ||Quinupristin dalfoppristin||+ | |||
|- | |||
| ||Linezolid|| | |||
|- | |||
| ||[[Daptomycin]]||0 | |||
|- | |||
| ||Colistimethate||0 | |||
|} | |||
===Key=== | |||
{{Template:Antibacterial Spectra Key}} | |||
==Table Overview== | |||
{{Clinically Relevant Bacteria}} | |||
==See Also== | ==See Also== | ||
*[[STDs]] | *[[STDs]] | ||
| Line 26: | Line 176: | ||
==Sources== | ==Sources== | ||
<references/> | <references/> | ||
[[Category:ID]] | [[Category:ID]] | ||
[[Category:GU]] | [[Category:GU]] | ||
Revision as of 07:57, 4 March 2014
Background
- Commonly known as gonorrhea
- Fastidious gram-negative cocci
Clinical Features
Differential Diagnosis
Workup
Management
- Proctitis
- Epididymitis
- Infectious Tenosynovitis
- Septic Arthritis (General)
- Orchitis
- Gonorrheal Conjunctivitis
Disposition
Antibiotic Sensitivities[1]
| Antibiotics | ' | N. gonorrhoeae |
| Penicillins | Penicillin G | 0 |
| Penicillin V | 0 | |
| Anti-Staphylocccal Penicillins | Methicillin | 0 |
| Nafcillin/Oxacillin | 0 | |
| Cloxacillin/Diclox. | 0 | |
| Amino-Penicillins | AMP/Amox | 0 |
| Amox/Clav | + | |
| AMP-Sulb | + | |
| Anti-Pseudomonal Penicillins | Ticarcillin | + |
| Ticar-Clav | + | |
| Pip-Taxo | + | |
| Carbapenems | Piperacillin | + |
| Doripenem | + | |
| Ertapenem | + | |
| Imipenem | + | |
| Meropenem | + | |
| Aztreonam | + | |
| Fluroquinolones | Ciprofloxacin | +* |
| Ofloxacin | +* | |
| Pefloxacin | +* | |
| Levofloxacin | +* | |
| Moxifloxacin | +* | |
| Gemifloxacin | ||
| Gatifloxacin | +* | |
| 1st G Cephalosporin | Cefazolin | + |
| 2nd G. Cephalosporin | Cefotetan | +/- |
| Cefoxitin | +/- | |
| Cefuroxime | +/- | |
| 3rd/4th G. Cephalosporin | CefoTAXime | +/- |
| Cefizoxime | +/- | |
| CefTRIAXone | + | |
| Ceftobiprole | + | |
| Ceftaroline | + | |
| CefTAZidime | +/- | |
| Cefepime | + | |
| Oral 1st G. Cephalosporin | Cefadroxil | 0 |
| Cephalexin | 0 | |
| Oral 2nd G. Cephalosporin | Cefaclor/Loracarbef | +/- |
| Cefproxil | +/- | |
| Cefuroxime axetil | +/- | |
| Oral 3rd G. Cephalosporin | Cefixime | + |
| Ceftibuten | +/- | |
| Cefpodox/Cefdinir/Cefditoren | + | |
| Aminoglycosides | Gentamicin | 0 |
| Tobramycin | 0 | |
| Amikacin | 0 | |
| Chloramphenicol | + | |
| Clindamycin | 0 | |
| Macrolides | Erythromycin | +/- |
| Azithromycin | +/- | |
| Clarithromycin | +/- | |
| Ketolide | Telithromycin | + |
| Tetracyclines | Doxycycline | +/- |
| Minocycline | +/- | |
| Glycylcycline | Tigecycline | + |
| Glyco/Lipoclycopeptides | Vancomycin | 0 |
| Teicoplanin | 0 | |
| Telavancin | 0 | |
| Fusidic Acid | + | |
| Trimethoprim | 0 | |
| TMP-SMX | +/- | |
| Urinary Agents | Nitrofurantoin | + |
| Fosfomycin | + | |
| Other | Rifampin | + |
| Metronidazole | 0 | |
| Quinupristin dalfoppristin | + | |
| Linezolid | ||
| Daptomycin | 0 | |
| Colistimethate | 0 |
Key
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia
Table Overview
| ||||||||||||||||||||||||||||||||||||||||
See Also
Sources
- ↑ Sanford Guide to Antimicrobial Therapy 2010
